RxDoctor Payments Data

Mitchell Clark, MD

Gynecologic Oncology · New Haven, CTNPI 1669817854

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,163 of the $9,138 with a category attached, or 78.4%. AbbVie accounts for 74.9% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $6,751, 9.1 times the $738 reported in 2021.

$9,138in general payments, 2019–2025

Across 17 payments — averaging $537.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Medtronic$1K
  • Stryker$738
  • Immunogen, Inc.$134
  • Genmab U.S., Inc.$133
  • Merck$41

What the payments were for

  • Consulting fees$7,16378%
  • Travel & lodging$1,18913%
  • Food & beverage$7879%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie9$6,846
Medtronic3$1,246
Stryker1$738
Immunogen, Inc.1$134
Genmab U.S., Inc.2$133
Merck1$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,138 in reported general payments places this provider in the 80th percentile of 25 gynecologic oncology providers in Connecticut.

See all gynecologic oncology providers in Connecticut

Medicare billing

Part B allowed, 2024
$79,597
Medicare patients
175
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →